Orphan drug status granted for GMI-1070 in Europe

GlaxoSmithKline, Pfizer venture ViivV reports results from clinical study ViiV Healthcare announced initial results from the Phase IIIb/IV FLAMINGO study.

http://www.theflyonthewall.com/permalinks/entry.php/PFEid1887035/PFE-Orphan-drug-status-granted-for-GMI-in-Europe